SSC MTS 2026 PYQ — Question 53

SSC MTS - 13 Feb 2026 - Shift 1 • General Awareness • Q53

In November 2024, IL-35-mediated immunotherapy has been developed as a new treatment for which type of diabetes?

Show answer & explanation

Correct answer: A

Explanation

Correct Answer:

Option 1: Type I

Explanation:

IL-35 is an immunoregulatory protein being used in the treatment of Type 1 diabetes. Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing beta cells. IL-35 helps regulate the immune system and may prevent this destruction. It is an emerging therapy in medical science and may play a key role in future treatments.

Additional Facts:

Option 2: Type III is not a valid classification.

Option 3: Type V is incorrect.

Option 4: Type VII is incorrect.

Probable Exam Questions:

Q: Cause of Type 1 diabetes?

A: Autoimmune reaction

Q: Which organ produces insulin?

A: Pancreas

Q: Type 2 diabetes is related to what?

A: Insulin resistance

Q: Diabetes is related to what?

A: Blood sugar